As for DSS, tumor patients with lower PPRC1 expression were found to have better survival outcomes in ACC, KIRP and LIHC, while higher PPRC1 was correlated with better DSS in Esophageal carcinoma(ESCA)patients (Figure 3A–D). This evidence concerns the gene PPRC1 and carcinoma of esophagus.